Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

La Torre, G., De Waure, C., Chiaradia, G., Mannocci, A., Specchia, M. L., Nicolotti, N., Ricciardi, G., The future of best investing in vaccines: the Health Technology Assessment approach, <<VACCINE>>, 2008; 26 (13): 1609-1610. [doi:10.1016/j.vaccine.2008.01.009] [http://hdl.handle.net/10807/30656]

The future of best investing in vaccines: the Health Technology Assessment approach

La Torre, Giuseppe;De Waure, Chiara;Chiaradia, Giacomina;Mannocci, Alice;Specchia, Maria Lucia;Nicolotti, Nicola;Ricciardi, Gualtiero
2008

Abstract

Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.
Inglese
La Torre, G., De Waure, C., Chiaradia, G., Mannocci, A., Specchia, M. L., Nicolotti, N., Ricciardi, G., The future of best investing in vaccines: the Health Technology Assessment approach, <>, 2008; 26 (13): 1609-1610. [doi:10.1016/j.vaccine.2008.01.009] [http://hdl.handle.net/10807/30656]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/30656
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact